Erytech Pharma

1 Main St Ste 3
Cambridge, MA 02142

Erytech Pharma, now known as PHAXIAM, is a biotechnology company based in Cambridge, MA, specializing in innovative therapies to combat antimicrobial resistance (AMR). They develop antibacterial treatments using bacteriophages, or phages, which are viruses that specifically target and combat bacteria, including antibiotic-resistant strains, offering a highly effective solution against microbial infections.

PHAXIAM was formed in June 2023 through the merger of two French biotechnology companies, ERYTECH and PHERECYDES, leveraging their complementary expertise and resources. With a mission to become a global leader in phage therapy, PHAXIAM aims to address the significant medical need caused by the growing problem of antimicrobial resistance.

Generated from the website

Own this business?
See a problem?

You might also like

Partial Data by Infogroup (c) 2025. All rights reserved.

Partial Data by Foursquare.